Pharmaco - Press Releases

Date	Title	Company
10-Oct-2023	Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)	Cosmo Pharmaceuticals N.V.
10-Oct-2023	Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone	Relief Therapeutics Holding SA
09-Oct-2023	IGEA Pharma N.V.: IGEA to update on RBCARE business combination	IGEA Pharma N.V.
09-Oct-2023	Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria	Newron Pharmaceuticals S.p.A.
06-Oct-2023	SCHOTT Pharma IPO: Early termination of stabilization period and full exercise of the Greenshoe Option	SCHOTT Pharma AG & Co. KGaA
06-Oct-2023	Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™	Marizyme, Inc.
06-Oct-2023	Bayer to partner with Twist Bioscience to accelerate drug discovery	Bayer
06-Oct-2023	Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery	Merck
06-Oct-2023	AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline	AbbVie
06-Oct-2023	New data at WMS 2023 reaffirm long-term efficacy of Nexviazyme® (avalglucosidase alfa) for the treatment of Pompe disease	Sanofi
06-Oct-2023	Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease	Boehringer Ingelheim
06-Oct-2023	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases	Pfizer
06-Oct-2023	EYLEA® HD (AFLIBERCEPT) INJECTION 8 MG TWO-YEAR RESULTS FROM PIVOTAL PULSAR TRIAL IN WET AGE-RELATED MACULAR DEGENERATION PRESENTED AT EURETINA	Regeneron
06-Oct-2023	Patient Organizations Gave $22 Billion in Grants for Research, Patient Services, and Access to Care Over the Last 5 Years, Says IQVIA Institute for Human Data Science	IQVIA
06-Oct-2023	Researchers design potential therapy to prevent brain deterioration in children with rare genetic conditions	Francis Crick Institute
06-Oct-2023	Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds	Viromed Medical AG
06-Oct-2023	Spexis to host business update conference call on October 9, 2023	Spexis AG
05-Oct-2023	Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery	Hoth Therapeutics
05-Oct-2023	Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	Impel Pharmaceuticals
05-Oct-2023	Biotest AG: Increase of the EBIT guidance	Biotest AG